StockWatch
·

HINDUSTAN FOODS LTD.

BSE: 519126

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
944.61
+10.1%+27.9%
Expenditure
889.83
+7.5%+27.5%
Net Profit
40.81
+92.1%+34.3%
OPM %
7.80%
+1.87pp-0.25pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00264.49528.98793.471.1KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Record PAT Masks a Tight Path to Full-Year Guidance

footwear recovery · guidance tightness · capex execution

Result verdictFollow-upQ1 FY2717 Aug 20266 minFMCG

Record PAT masks footwear headwinds; FY27 guidance at risk

footwear margin pressure · order book full · diversified platform

TranscriptDeep diveQ1 FY2717 Aug 20266 minFMCG

Hindustan Foods Q1 FY27: consolidated PAT +33% YoY to ₹42.8 Cr, margins expand, guidance held

contract manufacturing · margin expansion · capacity ramp up

ResultsQ1 FY2705 Aug 20263 minFMCG
Latest
Board Meeting4 Aug, 6:20 pm

Hindustan Foods Q1 FY27: consolidated PAT +33% YoY to ₹42.8 Cr, margins expand, guidance held

Hindustan Foods posted consolidated revenue of ₹1,201.08 Cr (+17.9% YoY, +7.6% QoQ) and PAT of ₹42.76 Cr (+32.8% YoY on the filing's restated ₹32.21 Cr base, +2.9% QoQ) for Q1 FY27, with EPS at ₹3.53 versus ₹2.70 a year ago. NPM improved to 3.56% from 3.16% YoY, though it eased from 3.72% in Q4 FY26. Neither this quarter nor the year-ago quarter carried an exceptional item, so the YoY comparison is clean at the P&L level — but part of the growth is inorganic: the quarter includes the newly acquired Ultra Beauty Care manufacturing facility at Aurangabad (₹21.81 Cr consideration, acquired April 1, 2026), and the company explicitly flags Q1 FY27 as not comparable to prior periods on this count. Standalone PAT of ₹40.81 Cr (+32.2% YoY) tracks the consolidated growth closely, with no material divergence between the two. Operating margin was roughly 8.3-8.4% this quarter versus about 7.9-8.0% a year ago (modest YoY expansion) but down from the 8.9-9.3% band in Q4 FY26 — cost of materials consumed rose to ₹964.32 Cr (80% of revenue) and manufacturing/operating costs to ₹72.84 Cr, while finance costs (₹23.40 Cr) and depreciation (₹26.18 Cr) both stepped up as newly added capacity, including the Aurangabad facility, comes onstream and utilization is still ramping. Management's press release title itself frames the quarter as 'Reaffirms Guidance' — the FY27 PAT guidance of ₹200-220 Cr given on the May 2026 concall stands, and Q1's ₹42.76 Cr consolidated PAT is about 19-21% of that full-year range, consistent with a back-half-loaded ramp as utilization improves through the year, as management had previously indicated. No quarter-specific street consensus was found; full-year FY27 analyst estimates (Trendlyne) point to roughly 20.5% revenue growth and 35.1% profit growth, against which Q1's 17.9% YoY revenue growth and 32.8% adjusted PAT growth run broadly in line, slightly behind on revenue. Management's own commentary attributes the print to 'robust execution and the continued strength of our diversified manufacturing platform,' tying it to capacity investments across beverages, ice cream and home & personal care — consistent with the quarter's acquisition-led capacity addition. Post quarter-end, the group's Silvassa manufacturing facility was disrupted by flooding (July 24, 2026); the filing notes the financial impact cannot yet be ascertained and the assets are insured — a Q2 FY27 item to watch rather than a Q1 drag. Paid-up equity capital rose to ₹24.24 Cr from ₹23.90 Cr, reflecting the preferential allotment to promoter-group entities completed in May 2026.

4 Aug 2026, 06:20 pm

Corporate Events

Board MeetingHNDFDS
2026
23Sep

Board Meeting

The 41st Annual General Meeting of the Members of the Compan…

BSE Filing
Board MeetingHNDFDS
2026
4Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingHNDFDS
2026
21May

Board Meeting

The board meeting is scheduled to consider and approve Audit…

BSE Filing
Board MeetingHNDFDS
2025
1Oct

Board Meeting

Notice of Closure of Trading Window

BSE Filing
Board MeetingHNDFDS
2024
12Nov

Board Meeting

Consideration And Approval Of Un-Audited Consolidated & Stan…

BSE Filing
Board MeetingHNDFDS
2024
1Oct

Board Meeting

Closure of Trading Window

BSE Filing
Board MeetingHNDFDS
2024
24Sep

Board Meeting

Scheme of Arrangement, Closure of Trading Window

BSE Filing
Board MeetingHNDFDS
2024
21May

Board Meeting

Consider and approve Audited Consolidated & Standalone Finan…

BSE Filing
Board MeetingHNDFDS
2024
8Feb

Board Meeting

Consider and approve Un-Audited Consolidated & Standalone Fi…

BSE Filing
Board MeetingHNDFDS
2023
22Sep

Board Meeting

Consider and approve Fund Raising

BSE Filing
Board MeetingHNDFDS
2023
11Aug

Board Meeting

Consider and approve Un-Audited Consolidated & Standalone Fi…

BSE Filing